image
Healthcare - Biotechnology - NASDAQ - CH
$ 1.91
-6.37 %
$ 4.72 M
Market Cap
-0.28
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
41.42%
Net Income Estimate
1375.75%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets NLS Pharmaceutics AG
image
NLSP has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart NLSP

image
EBIT FORECAST

EBIT Forecast Chart NLSP

image
NET INCOME FORECAST

Net Income Chart NLSP

image